WFM
TXMD icon

Wilmington Funds Management’s TherapeuticsMD TXMD Stock Holding History

Wilmington Funds Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-514
Closed -$162K – 823
2014
Q1 		$162K Buy
+514
New +$164K 0.02% 709

Other funds holding TXMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wilmington Funds Management's TXMD Position: Q2 2014 in Review

Wilmington Funds Management sold out of TherapeuticsMD (TXMD) in Q2 2014, closing a stake of 514 shares — an estimated $162K sold.

Wilmington Funds Management first reported a position in TXMD in Q1 2014 and held it in 1 quarter. The position peaked at $162K in Q1 2014. 87 funds tracked by Wall St. Rank hold TXMD as of Q2 2014.

  • Wilmington Funds Management reported no remaining TherapeuticsMD position as of Q2 2014 after selling out during the quarter.
  • Wilmington Funds Management sold 514 TherapeuticsMD shares in Q2 2014, an estimated $162K.
  • Wilmington Funds Management first reported a position in TherapeuticsMD in Q1 2014 and held it in 1 quarter.
  • Wilmington Funds Management's TherapeuticsMD position peaked at $162K in Q1 2014.
  • 87 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.